Latest Business and People News
Updated employee announcements, business news, awards, and recognition in the industry today.
People News
Bioclinica, a provider of solutions for clinical research, announces the addition of new team members Gavin Nichols as Chief Information Officer & Executive Vice President, Technology, and Elizabeth Edwards as President, Bioclinica Site Network, and a member of the executive management team. Additionally, Adrienne Rossi is promoted to the newly created position, Chief of Staff.
Clinipace Worldwide, a global full-service CRO, has announced the appointment of Charlene Dark as Vice President, global clinical analytics.
Karthik Kumar
InClinica, a global clinical CRO, announced that Karthik Kumar has been appointed Business Development Manager in the company’s office in Kuala Lumpur, Malaysia, and that Todd Koch has been appointed Global Trial Manager.
MMS Holdings Inc., a global CRO, announced the hiring of John Mitcheson as Senior Proposal Development Manager and Joy Willard, RN, BSN, PMP as Senior Project Manager.
PAREXEL announced the appointment of Peyton Howell as Chief Commercial and Strategy Officer, and also announced that their co-founder and Chairman of the Board of Directors, Josef von Rickenbach is the recipient of a 2018 Ellis Island Medal of Honor from the Ellis Island Honors Society.
Dr. Peter Hendrickx
SGS, a contract solutions provider, announced the appointment of Dr. Peter Hendrickx as Medical Director at the Clinical Pharmacology Unit located within the Antwerp ZNA Stuivenberg hospital.
Business News
IRB Services, an independent research ethics board, has changed its name to Advarra.
CROMSOURCE, an international CRO, announced the formalization of an expanded Flexible Resourcing Solutions offering, delivered by the TalentSource Life Sciences Department, with a new logo.
Recognition
PAREXEL announced that the Industry Standard Benchmark Report named the company’s ClinPhone Randomization and Trial Supply Management solution as the leader of Interactive Response Technology for the second consecutive time.
Rho, a full-service CRO, was named the 2018 Best CRO by Triangle Business Journal.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
